vs
Ceribell, Inc.（CBLL）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
STEM, INC.的季度营收约是Ceribell, Inc.的1.9倍（$47.1M vs $24.8M），STEM, INC.净利率更高（-33.9% vs -54.6%，领先20.7%）
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
CBLL vs STEM — 直观对比
营收规模更大
STEM
是对方的1.9倍
$24.8M
净利率更高
STEM
高出20.7%
-54.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.8M | $47.1M |
| 净利润 | $-13.5M | $-16.0M |
| 毛利率 | 87.3% | 48.9% |
| 营业利润率 | -58.9% | -17.7% |
| 净利率 | -54.6% | -33.9% |
| 营收同比 | — | -15.6% |
| 净利润同比 | — | 68.8% |
| 每股收益（稀释后） | $-0.35 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBLLSTEM
| Q4 25 | $24.8M | $47.1M | ||
| Q3 25 | $22.6M | $38.2M | ||
| Q2 25 | $21.2M | $38.4M | ||
| Q1 25 | $20.5M | $32.5M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | $17.2M | $29.3M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | — | $25.5M |
净利润CBLLSTEM
| Q4 25 | $-13.5M | $-16.0M | ||
| Q3 25 | $-13.5M | $-23.8M | ||
| Q2 25 | $-13.6M | $202.5M | ||
| Q1 25 | $-12.8M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $-10.4M | $-148.3M | ||
| Q2 24 | — | $-582.3M | ||
| Q1 24 | — | $-72.3M |
毛利率CBLLSTEM
| Q4 25 | 87.3% | 48.9% | ||
| Q3 25 | 88.3% | 35.5% | ||
| Q2 25 | 88.1% | 33.4% | ||
| Q1 25 | 87.9% | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | 87.3% | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
营业利润率CBLLSTEM
| Q4 25 | -58.9% | -17.7% | ||
| Q3 25 | -64.8% | -33.6% | ||
| Q2 25 | -70.5% | -34.8% | ||
| Q1 25 | -69.3% | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | -57.8% | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
净利率CBLLSTEM
| Q4 25 | -54.6% | -33.9% | ||
| Q3 25 | -59.6% | -62.2% | ||
| Q2 25 | -64.4% | 527.8% | ||
| Q1 25 | -62.4% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | -60.6% | -506.3% | ||
| Q2 24 | — | -1712.6% | ||
| Q1 24 | — | -283.9% |
每股收益（稀释后）CBLLSTEM
| Q4 25 | $-0.35 | $-4.40 | ||
| Q3 25 | $-0.37 | $-2.84 | ||
| Q2 25 | $-0.38 | $-1.79 | ||
| Q1 25 | $-0.36 | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | $-1.85 | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | — | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | $48.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $155.3M | $-249.4M |
| 总资产 | $195.8M | $308.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CBLLSTEM
| Q4 25 | $159.3M | $48.9M | ||
| Q3 25 | $168.5M | $43.1M | ||
| Q2 25 | $177.4M | $40.8M | ||
| Q1 25 | $182.7M | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | $14.1M | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
股东权益CBLLSTEM
| Q4 25 | $155.3M | $-249.4M | ||
| Q3 25 | $164.1M | $-235.7M | ||
| Q2 25 | $172.2M | $-214.1M | ||
| Q1 25 | $180.9M | $-417.5M | ||
| Q4 24 | — | $-398.4M | ||
| Q3 24 | $-136.0M | $-344.1M | ||
| Q2 24 | — | $-203.2M | ||
| Q1 24 | — | $371.6M |
总资产CBLLSTEM
| Q4 25 | $195.8M | $308.9M | ||
| Q3 25 | $199.5M | $362.6M | ||
| Q2 25 | $207.7M | $379.2M | ||
| Q1 25 | $213.5M | $405.1M | ||
| Q4 24 | — | $437.4M | ||
| Q3 24 | $47.1M | $537.8M | ||
| Q2 24 | — | $691.5M | ||
| Q1 24 | — | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | — |
| 自由现金流率自由现金流/营收 | -44.2% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.6M | — |
8季度趋势，按日历期对齐
经营现金流CBLLSTEM
| Q4 25 | $-10.8M | $8.2M | ||
| Q3 25 | $-11.1M | $11.4M | ||
| Q2 25 | $-7.5M | $-21.3M | ||
| Q1 25 | $-11.4M | $8.5M | ||
| Q4 24 | — | $-14.7M | ||
| Q3 24 | — | $-9.4M | ||
| Q2 24 | — | $-11.9M | ||
| Q1 24 | — | $-621.0K |
自由现金流CBLLSTEM
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率CBLLSTEM
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CBLLSTEM
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率CBLLSTEM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
STEM
暂无分部数据
